Dosage and administration
apply to underarms only
apply to underarms only
Drug Facts
Aluminum zirconium trichlorohydrex Gly 18% (anhydrous)
Antiperspirant
reduces underarm wetness
For external use only.
Do not use on broken skin
Ask a doctor before use if you have kidney disease
Stop use if rash or irritation occurs
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
cyclopentasiloxane, stearyl alcohol, mineral oil, dimethicone, talc, petrolatum, hydrogenated castor oil, fragrance, PPG-14 butyl ether, cyclodextrin, behenyl alcohol
FRESHER COLLECTION TM
Old Spice ®
DENALI TM
WITH SPRUCE
ANTI-PERSPIRANT
& DEODORANT
Aluminum zirconium trichlorohydrex Gly
ANTI-PERSPIRANT
NET WT. 2.6 OZ (73 g)
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| aluminum zirconium trichlorohydrex gly | ACTIVE INGREDIENT | T27D6T99LH | 3 | |
| Aluminum Zirconium Trichlorohydrex Gly | ACTIVE MOIETY | T27D6T99LH | 3 | |
| alkyl (C12-15) benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 3 | |
| castor oil | INACTIVE INGREDIENT | D5340Y2I9G | 3 | |
| cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 3 | |
| docosanol | INACTIVE INGREDIENT | 9G1OE216XY | 3 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | 3 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 3 | |
| phenyl trimethicone | INACTIVE INGREDIENT | DR0K5NOJ4R | 3 | |
| PPG-14 butyl ether | INACTIVE INGREDIENT | R199TJT95T | 3 | |
| stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 3 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 37000-747 | 37000-747-73, 37000-747-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMETHICONE | 92RU3N3Y1O | IACT |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| STEARYL ALCOHOL | 2KR89I4H1Y | IACT |
| PPG-14 BUTYL ETHER | R199TJT95T | IACT |
| CASTOR OIL | D5340Y2I9G | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| TALC | 7SEV7J4R1U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| DOCOSANOL | 9G1OE216XY | IACT |
| ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY | T27D6T99LH | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | POWDER / ORAL | 0.11 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| talc | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET / ORAL | 20 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| talc | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| talc | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| castor oil | CASTOR OIL | D5340Y2I9G | CAPSULE, EXTENDED RELEASE / ORAL | 47 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | SOLUTION / TOPICAL | 1.38 %w/w | ||
| castor oil | CASTOR OIL | D5340Y2I9G | GRANULE, FOR SUSPENSION / ORAL | 128 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | INJECTION / INTRAMUSCULAR | 885 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CAPSULE, EXTENDED RELEASE / ORAL | 72 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, EXTENDED RELEASE / ORAL | 244 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, FILM COATED / ORAL | 15.29 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | LOTION / TOPICAL | 1140 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| docosanol | DOCOSANOL | 9G1OE216XY | AEROSOL, FOAM / TOPICAL | 1.1 %w/w | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET / SUBLINGUAL | 1.6 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| talc | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| talc | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| talc | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8c2b602c-e167-912b-e053-2a95a90aa20b | 1c897fa0-8d5f-4e0a-a020-636a6c1bfbd4 | 2019-06-25 | Warnings | 8c2b602c-e167-912b-e053-2a95a90aa20b 1c897fa0-8d5f-4e0a-a020-636a6c1bfbd4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.